EUVIMEDEUVIMED entdecken
Systematische ÜbersichtVergleichsstudieNetzwerk-MetaanalyseOpen Access · CC BY 4.0

Oncological Outcomes and Response Rate After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Network Meta-Analysis Comparing Induction vs. Consolidation Chemotherapy vs. Standard Chemoradiation

Sergei Bedrikovetski, Luke Traeger, Warren Seow, Nagendra N Dudi-Venkata, Sudarsha Selva-Nayagam, Michael Penniment, Tarik Sammour

Clinical Colorectal Cancer · 2024

DOI: 10.1016/j.clcc.2024.06.001 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Colorectal Cancer, 2024. Verfasst von Sergei Bedrikovetski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Colorectal Unit, Royal Adelaide Hospital, Adelaide, Australia; Department of Surgical Specialties, Adelaide Medical School, Fa…. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Consolidation Chemotherapy, Induction Chemotherapy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TNT is now considered the preferred option for stage II-III locally advanced rectal cancer (LARC). However, the prognostic benefit and optimal sequence of TNT remains unclear. This network meta-analysis (NMA) compared short- and long-term outcomes amongst patients with LARC receiving total neoadjuvant therapy (TNT) as induction (iTNT) or consolidation chemotherapy (cTNT) with those receiving neoadjuvant chemoradiation (nCRT) alone. A systematic literature search was performed between 2012 and 2023. A Bayesian NMA was conducted using a Markov Chain Monte Carlo method with a random-effects model and vague prior distribution to calculate odds ratios (OR) with 95% credible intervals (CrI). The surface under the cumulative ranking (SUCRA) curves were used to rank treatment(s) for each outcome. In total, 11 cohorts involving 8360 patients with LARC were included. There was no significant difference in disease-free survival (DFS) and overall survival (OS) amongst the 3 treatments. Compared with nCRT, both cTNT (OR 2.36; 95% CrI, 1.57-3.66) and iTNT (OR 1.99; 95% CrI, 1.44-2.95) significantly improved complete response (CR) rate. Notably, cTNT ranked as the best treatment for CR (SUCRA 0.90) and iTNT as the best treatment for 3-year DFS and OS (SUCRA 0.72 and 0.87, respectively). Both iTNT and cTNT strategies significantly improved CR rates compared with nCRT. cTNT was ranked highest for CR rates, while iTNT was ranked highest for 3-year survival outcomes. However, no other significant differences in DFS, OS, sphincter-saving surgery, R0 resection and postoperative complications were found amongst the treatment groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsNeoadjuvant TherapyConsolidation ChemotherapyInduction ChemotherapyChemoradiotherapyHumansDisease-Free SurvivalBayes TheoremTreatment OutcomeNeoplasm Staging

Stichwörter der Autor:innen

Complete responseDisease-free survivalNeoadjuvant chemoradiotherapyPostoperative complicationsSurvival

Autor:innen und Institutionen

  • Department of Surgery, Colorectal Unit, Royal Adelaide Hospital, Adelaide, Australia; Department of Surgical Specialties, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide…
  • Department of Surgery, Colorectal Unit, Royal Adelaide Hospital, Adelaide, Australia.
  • Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, Australia.
  • Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, Australia.

Zitieren

APA

Bedrikovetski, S., Traeger, L., Seow, W., Dudi-Venkata, N. N., Selva-Nayagam, S., Penniment, M., & Sammour, T. (2024). Oncological Outcomes and Response Rate After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Network Meta-Analysis Comparing Induction vs. Consolidation Chemotherapy vs. Standard Chemoradiation. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2024.06.001

Vancouver

Bedrikovetski S, Traeger L, Seow W, Dudi-Venkata NN, Selva-Nayagam S, Penniment M, et al. Oncological Outcomes and Response Rate After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Network Meta-Analysis Comparing Induction vs. Consolidation Chemotherapy vs. Standard Chemoradiation. Clinical Colorectal Cancer. 2024. doi:10.1016/j.clcc.2024.06.001

BibTeX
@article{Bedrikovetski2024,
  author = {Bedrikovetski, Sergei and Traeger, Luke and Seow, Warren and Dudi-Venkata, Nagendra N and Selva-Nayagam, Sudarsha and Penniment, Michael and Sammour, Tarik},
  title = {Oncological Outcomes and Response Rate After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Network Meta-Analysis Comparing Induction vs. Consolidation Chemotherapy vs. Standard Chemoradiation},
  journal = {Clinical Colorectal Cancer},
  year = {2024},
  doi = {10.1016/j.clcc.2024.06.001}
}
Kostenlos starten →